DPHARMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Duopharma Biotech Bhd

Watchlist Manager

Watchlist

Price: 1.1 MYR Market Closed

Market Cap: 1.1B MYR

D	Duopharma Biotech Bhd KLSE:DPHARMA	MY
	Planet Properindo Jaya Tbk PT IDX:PLAN	ID
I	InstallatoerGruppen A/S CSE:IG	DK
T	TRC Synergy Bhd KLSE:TRC	MY
	Impax Asset Management Group PLC F:LW4	UK

Profitability Summary

Duopharma Biotech Bhd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

41%

Sustainable 3Y Average Gross Margin

38%

Gross Margin is Increasing

40% > 41%

Healthy Operating Margin

16%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

12% > 16%

Healthy Net Margin

11%

Low 3Y Average Net Margin

Net Margin is Increasing

9% > 11%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.